指南与共识消化内镜消化道肿瘤与早癌

Colon-Pilot:生成式AI自动生成结肠镜监测建议并对标2024 ACG/ASGE质量基准

Colon-Pilot: A Generative AI Tool for Automated Colonoscopy Surveillance Recommendations and 2024 ACG/ASGE Quality Benchmarking.
指南 / 共识 · Am J Gastroenterol · 2026-02-10

Colon-Pilot是基于GPT-4o的大语言模型临床决策支持系统,在596例结肠镜中自动生成监测建议并与2020 USMSTF指南和专家共识对比,指南一致准确率97.5%(κ=0.970),高于原内镜医师的69.7%(κ=0.781);在42,632例结肠镜中自动计算2024 ACG/ASGE质量指标,腺瘤检出率49.8%、无蒂锯齿状病变检出率17.7%、肠道准备充分率91.8%、盲肠插管率97.4%,均超过基准。

要点

  • Colon-Pilot自动生成87.6%病例的监测建议,12.4%触发人工复核。
  • 自动病例指南一致准确率97.5%,显著高于内镜医师的69.7%。
  • 企业级数据质量指标均超过2024 ACG/ASGE基准。

核心结论

  • Colon-Pilot在应用监测指南和自动化质量基准方面表现出高保真度,指南依从性优于未辅助的内镜医师。

研究设计与样本

  • 研究评估Colon-Pilot的两种运行模式:对596例结肠镜进行人工在环临床决策支持验证,与2020 USMSTF指南和专家共识对比;对Mayo Clinic Health System的42,632例结肠镜进行自动化行政审计,计算2024 ACG/ASGE优先质量指标。

主要发现

  • Colon-Pilot对596例中522例(87.6%)生成建议,12.4%标记为人工复核。
  • 自动病例的指南一致准确率为97.5%(Cohen κ=0.970),原内镜医师建议为69.7%(κ=0.781)。
  • 不一致的AI病例(n=13)中最常见的是推荐了比适当更长的间隔(62%)。
  • 企业数据集上计算的质量指标超过2024年目标:腺瘤检出率49.8%(≥35%)、无蒂锯齿状病变检出率17.7%(≥6%)、肠道准备充分率91.8%(≥90%)、盲肠插管率97.4%(≥95%)。

关键数值与推荐

  • 2020 USMSTF指南用于监测风险分层。
  • 2024 ACG/ASGE质量基准:腺瘤检出率≥35%、无蒂锯齿状病变检出率≥6%、肠道准备充分率≥90%、盲肠插管率≥95%。

临床怎么用

  • Colon-Pilot可自动化生成结肠镜监测建议并对标质量基准,减少人工负担,提高指南依从性和报告效率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: High-quality colonoscopy requires accurate risk stratification for surveillance per the 2020 US Multi-Society Task Force guidelines and adherence to 2024 American College of Gastroenterology/American Society for Gastrointestinal Endoscopy quality benchmarks. Both are operationally challenging in clinical practice. We developed and validated Colon-Pilot, a large language model-powered clinical decision support system using GPT-4o to automate and standardize both functions. METHODS: The system was evaluated in 2 operational modes: (i) a human-in-the-loop clinical decision support validation of surveillance recommendations for 596 colonoscopies, comparing concordance with 2020 US Multi-Society Task Force guidelines against expert consensus, and (ii) an automated administrative audit applying Colon-Pilot to 42,632 colonoscopies across the Mayo Clinic Health System to calculate 2024 American College of Gastroenterology/American Society for Gastrointestinal Endoscopy priority quality indicators. Recommendations were autogenerated unless predefined safety criteria triggered manual review. RESULTS: Colon-Pilot issued recommendations for 522 of 596 cases (87.6%) and flagged 12.4% for manual review. For automated cases, guideline-concordant accuracy was 97.5% (Cohen κ = 0.970) versus 69.7% (κ = 0.781) for original endoscopist recommendations. Discordant artificial intelligence (AI) cases (n = 13) most often recommended longer-than-appropriate intervals (62%). Applied to the enterprise data set, Colon-Pilot calculated performance exceeding 2024 targets: adenoma detection rate 49.8% (≥35%), sessile serrated lesion detection rate 17.7% (≥6%), bowel preparation adequacy 91.8% (≥90%), and cecal intubation rate 97.4% (≥95%). DISCUSSION: Colon-Pilot demonstrated high fidelity in applying surveillance guidelines and automated quality benchmarking, outperforming unassisted endoscopists in guideline adherence. By combining safety protocols with large-scale automated reporting, it offers a scalable solution for improving both efficiency and quality in colorectal cancer prevention.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Garg SK, Mau B, Hubers J, et al. Colon-Pilot: A Generative AI Tool for Automated Colonoscopy Surveillance Recommendations and 2024 ACG/ASGE Quality Benchmarking. Am J Gastroenterol. 2026. PMID: 41665228. doi:10.14309/ajg.0000000000003946

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。